Phencyclidine (PCP) immunoassay reagents, calibrators,&quality control (THC 40 & 60)
Ended Purchase Order Awarded Last action
- Contract number
- 959P0020P0010
- Awardee
-
Microgenics Corporation UEI E7WGWEK19Y79
- Awarding agency
-
CSOSA Pretrial Services Agency
CSOSA
- Obligated
- $103,910
Award facts
- Opportunity
-
- Phencyclidine (PCP) Immunoassay Reagents, Calibrators, Quality Control & Marijuana (THC) Special Notice · 959P0020Q0014 · Posted Feb 26, 2020
- Phencyclidine (PCP) Reagents, Calibrators, and Quality Control (QC) Material for Tetrahydrocannabinol (THC) 40 and THC 60 Award Notice · Posted Aug 13, 2020
- Contract value 46% obligated
-
- $135,000.00 Current, with exercised options
- $225,000.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Washington, DC 20002, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$19,840 | |
| Exercise an Option | $45,000 | |
| Funding Only Action | $11,250 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $11,250 | |
| Supplemental Agreement for work within scope | $11,250 | |
| Original award | $45,000 |
About this award
On May 12, 2020, the Court and Community Supervision Services (CSOSA) Pretrial Services Agency awarded a $225,000 firm fixed-price purchase order to Microgenics Corporation for phencyclidine (PCP) immunoassay reagents, calibrators, and quality control materials designated for THC 40 and THC 60 testing applications. The contract was solicited through a special notice posted on February 26, 2020, with a submission deadline of March 5, 2020, and is scheduled for ultimate completion by May 11, 2025. As a civilian agency contract, this award supports CSOSA's pretrial services operations in Washington, DC, with no set-aside designation applied.
Microgenics Corporation, a subsidiary of Thermo Electron Corporation and a established federal contractor specializing in clinical diagnostic products, is well-positioned to fulfill this requirement through its Clinical Diagnostics Division. The company has demonstrated sustained success in delivering immunoassay reagent test kits to federal agencies, particularly the Department of Defense and Department of Veterans Affairs, supporting substance abuse testing and treatment programs. Through multiple indefinite delivery contracts valued at several million dollars collectively, Microgenics supplies critical diagnostic reagents across a range of controlled substance detection applications, underscoring its capability to deliver specialized toxicology testing solutions to support CSOSA's pretrial drug screening operations.
Quick answers
Who was awarded contract 959P0020P0010?
959P0020P0010 was awarded to Microgenics Corporation by CSOSA Pretrial Services Agency (CSOSA) on May 12, 2020.
How much is contract 959P0020P0010 worth?
The government has obligated $103,910 on 959P0020P0010. Its current value, with exercised options, is $135,000. Its potential value, with all options, is $225,000.
Was contract 959P0020P0010 competed?
The extent of competition for 959P0020P0010 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award